88 related articles for article (PubMed ID: 8176455)
1. A technique to localize activation in the human brain with technetium-99m-HMPAO SPECT: a validation study using visual stimulation.
Crosson B; Williamson DJ; Shukla SS; Honeyman JC; Nadeau SE
J Nucl Med; 1994 May; 35(5):755-63. PubMed ID: 8176455
[TBL] [Abstract][Full Text] [Related]
2. Difference images calculated from ictal and interictal technetium-99m-HMPAO SPECT scans of epilepsy.
Zubal IG; Spencer SS; Imam K; Seibyl J; Smith EO; Wisniewski G; Hoffer PB
J Nucl Med; 1995 Apr; 36(4):684-9. PubMed ID: 7699465
[TBL] [Abstract][Full Text] [Related]
3. Brain SPECT evaluation of the visual cortex in amblyopia.
Kabasakal L; Devranoğlu K; Arslan O; Erdil TY; Sönmezoğlu K; Uslu I; Tolun H; Isitman AT; Ozker K; Onsel C
J Nucl Med; 1995 Jul; 36(7):1170-4. PubMed ID: 7790940
[TBL] [Abstract][Full Text] [Related]
4. A reference method for correlation of anatomic and functional brain images: validation and clinical application.
Mountz JM; Zhang B; Liu HG; Inampudi C
Semin Nucl Med; 1994 Oct; 24(4):256-71. PubMed ID: 7817199
[TBL] [Abstract][Full Text] [Related]
5. Computer-assisted superimposition of magnetic resonance and high-resolution technetium-99m-HMPAO and thallium-201 SPECT images of the brain.
Holman BL; Zimmerman RE; Johnson KA; Carvalho PA; Schwartz RB; Loeffler JS; Alexander E; Pelizzari CA; Chen GT
J Nucl Med; 1991 Aug; 32(8):1478-84. PubMed ID: 1869966
[TBL] [Abstract][Full Text] [Related]
6. Visual stimulation increases technetium-99m-HMPAO distribution in human visual cortex.
Woods SW; Hegeman IM; Zubal IG; Krystal JH; Koster K; Smith EO; Heninger GR; Hoffer PB
J Nucl Med; 1991 Feb; 32(2):210-5. PubMed ID: 1992020
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMPAO brain perfusion tomography atlas using a high resolution SPECT system.
Matsuda H; Oskoie SD; Kinuya K; Tsuji S; Sumiya H; Tonami N; Hisada K
Clin Nucl Med; 1990 Jun; 15(6):428-31. PubMed ID: 2354585
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance.
Ichise M; Chung DG; Wang P; Wortzman G; Gray BG; Franks W
J Nucl Med; 1994 Feb; 35(2):217-26. PubMed ID: 8294988
[TBL] [Abstract][Full Text] [Related]
9. Mean regional cerebral blood flow images of normal subjects using technetium-99m-HMPAO by automated image registration.
Imran MB; Kawashima R; Sato K; Kinomura S; Ito H; Koyama M; Goto R; Ono S; Yoshioka S; Fukuda H
J Nucl Med; 1998 Jan; 39(1):203-7. PubMed ID: 9443762
[TBL] [Abstract][Full Text] [Related]
10. Functional deficits in autistic disorder: characterization by technetium-99m-HMPAO and SPECT.
Mountz JM; Tolbert LC; Lill DW; Katholi CR; Liu HG
J Nucl Med; 1995 Jul; 36(7):1156-62. PubMed ID: 7790938
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-HMPAO SPECT in partial status epilepticus.
Tatum WO; Alavi A; Stecker MM
J Nucl Med; 1994 Jul; 35(7):1087-94. PubMed ID: 8014662
[TBL] [Abstract][Full Text] [Related]
12. Interactive three-dimensional region of interest analysis of HMPAO SPECT brain studies.
Hooper HR; McEwan AJ; Lentle BC; Kotchon TL; Hooper PM
J Nucl Med; 1990 Dec; 31(12):2046-51. PubMed ID: 2266407
[TBL] [Abstract][Full Text] [Related]
13. [A method of adjusting and evaluating MRT and SPECT tomograms for comparing cerebral morphology with cerebrovascular regulation].
Kaiser HJ; Reiche W; Büll U
Nuklearmedizin; 1990 Feb; 29(1):13-8. PubMed ID: 2157197
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-HMPAO brain SPECT in Behçet's disease.
García-Burillo A; Castell J; Fraile M; Jacas C; Vilardell M; Ortega D; Bosch JA
J Nucl Med; 1998 Jun; 39(6):950-4. PubMed ID: 9627324
[TBL] [Abstract][Full Text] [Related]
15. SPECT in patients with cortical visual loss.
Silverman IE; Galetta SL; Gray LG; Moster M; Atlas SW; Maurer AH; Alavi A
J Nucl Med; 1993 Sep; 34(9):1447-51. PubMed ID: 8355062
[TBL] [Abstract][Full Text] [Related]
16. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique.
Ito H; Kawashima R; Awata S; Ono S; Sato K; Goto R; Koyama M; Sato M; Fukuda H
J Nucl Med; 1996 Mar; 37(3):410-4. PubMed ID: 8772633
[TBL] [Abstract][Full Text] [Related]
17. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington's disease.
Ichise M; Toyama H; Fornazzari L; Ballinger JR; Kirsh JC
J Nucl Med; 1993 Aug; 34(8):1274-81. PubMed ID: 8326384
[TBL] [Abstract][Full Text] [Related]
18. Methodological features for neurostimulation studies with technetium-99m-HMPAO SPECT.
Le Scao Y; Turzo A; Morin PP; Baulieu JL
J Nucl Med; 1993 Jul; 34(7):1217. PubMed ID: 8315506
[No Abstract] [Full Text] [Related]
19. HMPAO-SPECT and MRI in acute disseminated encephalomyelitis.
Broich K; Horwich D; Alavi A
J Nucl Med; 1991 Oct; 32(10):1897-900. PubMed ID: 1919728
[No Abstract] [Full Text] [Related]
20. Asymmetry of basal ganglia perfusion in Tourette's syndrome shown by technetium-99m-HMPAO SPECT.
Klieger PS; Fett KA; Dimitsopulos T; Kurlan R
J Nucl Med; 1997 Feb; 38(2):188-91. PubMed ID: 9025732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
